Business
10x Genomics Debuts Range of New Products at AGBT
Ships Chromium Connect; Unveils Dozen New Applications to Advance Genomics PLEASANTON, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq:
About this update from 10x Genomics, Inc.
[{"type":"text","content":"Ships Chromium Connect; Unveils Dozen New Applications to Advance Genomics\nPLEASANTON, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG) today announced a broad range of new products at the Advances in Genome Biology and Technology (AGBT) General Meeting, as well as new capabilities for existing products. Today’s announcements further 10x Genomics’ commitment to helping researchers see biology at greater resolution and scale, conduct more simultaneous measurements, and have richer context for their work regardless of the size or location of their labs.\n The company also announced that its new Chromium Connect system is now shipping. Chromium Connect automates single cell workflows, maximizing lab productivity while reducing user variability to generate consistent, reproducible single cell sequencing results. 10x Genomics unveiled the development of four new Targeted Gene Expression products for Pan-Cancer, Immunology, Gene Signature, and Neuroscience that will work across the company’s Chromium and Visium platforms. Targeted Gene Expression products are expected to ship in mid-2020. “The new products and features we have in the pipeline will empower scientists to study biology at greater resolution and scale than ever before,” said Michael Schnall-Levin, senior vice president of research and development and founding scientist at 10x Genomics. “Last year at AGBT we previewed our Visium Spatial Gene Expression Solution, which has now shipped to customers around the world. With today’s announcement of over a dozen product offerings, we are on a rapid rate of innovation to make the Century of Biology a reality.” Continuing its role as a pioneer in single cell genomics, the company also revealed the following new applications for its Chromium platform: Chromium Single Cell ATAC + Gene Expression - For the first time, 10x Genomics customers will be able to measure simultaneous epigenetic and gene expression markers from the same single cell at scale. The product is expected to arrive in the second half of the year.CellPlex - The new offering will provide flexibility for customers to run experiments on a scale of up to 160K cells or multiplex up to 96 samples per run on an 8-channel chip. In combination with other 10x Genomics innovations, this offering will allow for routine million-cell experiments. CellPle...